Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
NASDAQ:MREO
Price:
0.33655
USD
2.29%
Market Cap:
$53.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
UK |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SZSE:002099
|
CN |
|
Fast Food Indonesia Tbk PT
IDX:FAST
|
ID |
|
LifeVantage Corp
NASDAQ:LFVN
|
US |
|
Shenzhen Huijie Group Co Ltd
SZSE:002763
|
CN |
|
Haitian International Holdings Ltd
HKEX:1882
|
CN |
|
Kalyani Forge Ltd
NSE:KALYANIFRG
|
IN |
|
WuXi Xinje Electric Co Ltd
SSE:603416
|
CN |
|
Mapletree Commercial Trust
OTC:MPCMF
|
SG |
Multiples-Based Value
The Multiples-Based Value of one
MREO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.33655 USD,
Mereo Biopharma Group PLC
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MREO Multiples-Based Value
LOCKED
Multiples Across Competitors
MREO Competitors Multiples
Mereo Biopharma Group PLC Competitors
Mereo Biopharma Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
52.4m USD | 80.9 | -1 | 0 | 0 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.7B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.1 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
